Posttransplantation Thrombotic Thrombocytopenic Purpura: A Single-Center Experience and a Contemporary Review
Michelle A. Elliott(Mayo Clinic), Mark R. Litzow(Dana-Farber Cancer Institute), Ayalew Tefferi(Mayo Clinic), Ivana N. Micallef(Mayo Clinic), Stephen M. Ansell(Mayo Clinic), Elizabeth Plumhoff(Mayo Clinic), Morie A. Gertz(Medical University of South Carolina), David J. Inwards(Mayo Clinic), Martha Q. Lacy(Mayo Clinic), Dennis A. Gastineau(Mayo Clinic), William L. Nichols(Mayo Clinic), Angela Dispenzieri(Mayo Clinic)
Cited by 110
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k